Eisen Life Technology

http://www.aisenlefu.com/  

Chinese manufacturer of a topical gel for rapid hemostasis and enhanced healing of burns and wounds seeks distributor in Belarus

COUNTRY OF ORIGIN

China

IDENTIFIER

BO15420

PUBLISHED

2025-11-25

LAST UPDATE

2025-11-25

DEADLINE

Linked profile in other language
Responsible
Liangbin Hu
4437@sust.edu.cn
Summary
A company from China manufacturing a topical gel for healing of burns and wounds is looking for distributors in Belarus and other Eurasian Economic Union countries. The gel was specially developed to provide rapid hemostasis also have strong antibacterial and anti-inflammatory effects.
Description
A Chinese company has developed and produces a gel for healing burns and wounds. The gel's biomimetic formula, based on a patented iron-containing component, provides dual action:
1) physical: polysaccharides in gel instantly form a protective matrix over the wound;
2) biological: in a novel, non-antibiotic approach, the iron-based active component simultaneously accelerates natural clotting cascades and promotes cellular repair processes.

Rapid bleeding control is achieved through platelet aggregation, which reduces blood loss and the risk of secondary infection. Accelerated healing is achieved through collagen production and stimulation of fibroblast proliferation. At the same time, inflammation is suppressed, providing pain relief and reducing itching.

The developed gel does not contain hormones and does not develop resistance to the drug, making it suitable for treating burns and wounds in patients, including pregnant women, children, and the elderly.

The product has undergone preclinical trials and safety studies and is registered in China as a disinfectant (Xiaozihao). Clinical trials are optional for this category of product, but the company has positive experience using the product for treating deep pressure ulcers in elderly patients, for post-hemorrhoidectomy care, and for skin care in cancer patients after radiation therapy.

The company is seeking distributors in Belarus, Russia, and other EAEU countries. The company is willing to provide potential partners with gel samples for testing and discuss agreement terms based on the results.
Advantages and Innovations
The product was specially developed for rapid hemostasis (less than 1 minute).

In controlled trials conducted in collaboration with military medical institutions, the product led in wound healing speed compared to the well-known domestic wound care product "Jieyou Shen" and a traditional MEBO (Moist Exposed Burn Ointment).

It's cool and refreshing hydrogel texture avoids the greasy feel of traditional ointments, offering a superior user experience.

The product was developed and is manufactured by Ningbo Eisen Life Technology Co., Ltd. in China. This vertically integrated model - combining R&D and production - streamlines processes, reduces intermediate links, and helps protect our partners' profit margins. It ensures full control over product quality, reliability of a supply chain, and a highly competitive end-user price of approximately 15 RMB (2 USD).
Stage of development
Already on the market
Comments regarding stage of development
The gel has been registered in China as a "Disinfection Product Category" (Xiaozihao) and can be obtained in pharmacies.
Meanwhile, to meet broader market access requirements, the company is actively advancing the application for U.S. FDA OTC (Over-the-Counter) certification.
IPR status
Patents granted
Comments regarding IPS status
The product was patented in June 2023. At present it is protected by 5 Chinese and 2 U.S. patents:
US11957712B2
US12268711B2
Sector group
Healthcare

Client information

Year established
2023
Already engaged in transnational cooperation
Yes
Languages spoken
Chinese
English
Russian

Information about partnership

Type of partnership considered
Distribution services agreement
Type and role of partner sought
As part of a distribution agreement, the Chinese company is seeking a partner in Belarus and other Eurasian countries with experience in distributing pharmaceutical products.
Type and size of partner sought
251-500
> 500
SME <= 10
SME 11-50
SME 51-250
Countries for dissemination
Belarus
Russia

Attachments

Views: 68
Statistics since 25.11.2025 10:44:21